Citi reiterates these 2 medtech stocks as its top picks in the sector
FROM THE WIRE · FINANCE.YAHOO.COM
Investing.com-- Citi reiterated its top picks in the medtech sector, highlighting Abbott Laboratories and Dexcom as standout opportunities while pointing to diverging fortunes across the industry. Before you buy NVIDIA: our AI model's stock picks are beating the market by 120%+.…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA rating reiteration by a major bank on medtech stocks is relevant but ordinary in research flow.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Citi reiterated Abbott Laboratories and Dexcom as top picks in the medtech sector.
- 02Abbott benefits from low Q3 2026 expectations with recovery potential into 2027.
- 03Abbott's continuous glucose monitoring (CGM) business is the key swing factor, with Q1 sales of $2 billion up 7.5%.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Abbott Laboratories98.73 USDMarket closedtoday +0.58%Positive DexCom, Inc.84.30 USDMarket closedtoday +1.09%Positive
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets